Northern Trust’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,588
Closed -$11.1K 4461
2025
Q4
$11.1K Buy
2,588
+2,121
+454% +$23.3K ﹤0.01% 4430
2025
Q3
$5.52K Hold
467
﹤0.01% 4417
2025
Q2
$10.1K Hold
467
﹤0.01% 4373
2025
Q1
$12.4K Hold
467
﹤0.01% 4376
2024
Q4
$28.8K Buy
+467
New +$27K ﹤0.01% 4340
2024
Q1
Sell
-91
Closed -$12.4K 4446
2023
Q4
$12.4K Hold
91
﹤0.01% 4407
2023
Q3
$17.6K Hold
91
﹤0.01% 4351
2023
Q2
$18.8K Hold
91
﹤0.01% 4418
2023
Q1
$22.8K Buy
91
+23
+34% +$6.46K ﹤0.01% 4426
2022
Q4
$16.1K Hold
68
﹤0.01% 4524
2022
Q3
$28K Buy
68
+37
+119% +$21.3K ﹤0.01% 4477
2022
Q2
$10K Hold
31
﹤0.01% 4692
2022
Q1
$13K Hold
31
﹤0.01% 4687
2021
Q4
$42K Hold
31
﹤0.01% 4617
2021
Q3
$50K Hold
31
﹤0.01% 4534
2021
Q2
$58K Buy
+31
New +$60.3K ﹤0.01% 4467

Other funds holding GOVX

Northern Trust's GOVX Position: Q1 2026 in Review

Northern Trust sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 2,588 shares — an estimated $11.1K sold.

Northern Trust first reported a position in GOVX in Q2 2021 and held it in 16 quarters. The position peaked at $58K in Q2 2021. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

  • Northern Trust reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 2,588 GeoVax Labs shares in Q1 2026, an estimated $11.1K.
  • Northern Trust first reported a position in GeoVax Labs in Q2 2021 and held it in 16 quarters.
  • Northern Trust's GeoVax Labs position peaked at $58K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.